NBC Securities Inc. Buys 3,590 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

NBC Securities Inc. lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 119,666.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,593 shares of the biotechnology company's stock after purchasing an additional 3,590 shares during the quarter. NBC Securities Inc.'s holdings in Axon Enterprise were worth $1,889,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of AXON. Vanguard Group Inc. raised its position in Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock valued at $5,019,886,000 after purchasing an additional 275,959 shares during the last quarter. Geode Capital Management LLC increased its holdings in Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock worth $1,095,542,000 after purchasing an additional 65,097 shares in the last quarter. Capital World Investors increased its holdings in Axon Enterprise by 86.4% in the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock worth $1,079,145,000 after purchasing an additional 841,772 shares in the last quarter. Alliancebernstein L.P. grew its stake in Axon Enterprise by 273.8% in the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after acquiring an additional 812,337 shares during the period. Finally, Norges Bank acquired a new stake in Axon Enterprise in the fourth quarter valued at approximately $482,081,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 9,000 shares of the company's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $683.31, for a total value of $6,149,790.00. Following the completion of the transaction, the president now directly owns 308,714 shares in the company, valued at approximately $210,947,363.34. This represents a 2.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 43,969 shares of company stock worth $29,909,594. 4.40% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

Axon Enterprise stock traded up $5.22 during midday trading on Friday, hitting $793.58. 131,265 shares of the company's stock were exchanged, compared to its average volume of 728,502. Axon Enterprise, Inc. has a 52-week low of $278.24 and a 52-week high of $798.16. The stock has a 50-day moving average price of $638.88 and a two-hundred day moving average price of $615.19. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market cap of $61.78 billion, a P/E ratio of 205.06, a PEG ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. During the same period in the previous year, the business earned $1.15 earnings per share. The firm's revenue was up 31.3% on a year-over-year basis. On average, equities research analysts forecast that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on AXON shares. Barclays lifted their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Bank of America boosted their price objective on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday. Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Needham & Company LLC boosted their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. Finally, The Goldman Sachs Group boosted their price objective on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise presently has a consensus rating of "Moderate Buy" and a consensus target price of $699.55.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.